Ascendis Pharma (ASND) PT Lowered to $326 at Wells Fargo
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $263.04 --0%
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $326.00 (from $330.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Lowered to $273 at Morgan Stanley
- H.C. Wainwright Starts Ascendis Pharma (ASND) at Buy
- Petroreconcavo SA (RECV3:BZ) PT Lowered to R$12 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
